← Back to Search

Procedure

Deep Brain Stimulation for Movement Disorders

N/A
Recruiting
Led By Kareem A Zaghloul, M.D.
Research Sponsored by National Institute of Neurological Disorders and Stroke (NINDS)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be 18 years of age or older.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying how deep brain stimulation surgery affects people with movement disorders.

Who is the study for?
This trial is for adults over 18 with movement disorders like Parkinson's disease, essential tremor, and dystonia that aren't well-managed by medication. Candidates must be able to understand and agree to the study's procedures.
What is being tested?
The trial studies Deep Brain Stimulation (DBS) surgery effects on movement disorders. It involves implanting a device to stimulate brain areas linked to movement and recording nerve cell function during surgery.
What are the potential side effects?
Potential side effects of DBS may include headache, infection at the site of surgery or stimulator, speech problems, balance issues, numbness or tingling sensations, and unwanted mood changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
physiology and efficacy of DBS surgery for movement disorders

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: treatment armExperimental Treatment2 Interventions
patients with Parkinson's Disease, dysonia, and essential tremor
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Deep Brain Stimulation
2011
Completed Phase 2
~710

Find a Location

Who is running the clinical trial?

National Institute of Neurological Disorders and Stroke (NINDS)Lead Sponsor
1,372 Previous Clinical Trials
650,709 Total Patients Enrolled
Kareem A Zaghloul, M.D.Principal InvestigatorNational Institute of Neurological Disorders and Stroke (NINDS)
7 Previous Clinical Trials
631 Total Patients Enrolled

Media Library

Deep Brain Stimulation (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT01581580 — N/A
Parkinson's Disease Research Study Groups: treatment arm
Parkinson's Disease Clinical Trial 2023: Deep Brain Stimulation Highlights & Side Effects. Trial Name: NCT01581580 — N/A
Deep Brain Stimulation (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01581580 — N/A
~56 spots leftby Dec 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top